Pinnacle Associates’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5M | Sell |
|
|||||
|
2025
Q1 | $18.4M | Buy |
|
|||||
|
2024
Q4 | $19.1M | Buy |
|
|||||
|
2024
Q3 | $23.2M | Buy |
|
|||||
|
2024
Q2 | $21.6M | Sell |
|
|||||
|
2024
Q1 | $19.9M | Buy |
|
|||||
|
2023
Q4 | $23.2M | Sell |
|
|||||
|
2023
Q3 | $21M | Sell |
|
|||||
|
2023
Q2 | $19.6M | Sell |
|
|||||
|
2023
Q1 | $17.5M | Sell |
|
|||||
|
2022
Q4 | $18.7M | Sell |
|
|||||
|
2022
Q3 | $22.2M | Sell |
|
|||||
|
2022
Q2 | $19.1M | Sell |
|
|||||
|
2022
Q1 | $19.3M | Sell |
|
|||||
|
2021
Q4 | $16.5M | Sell |
|
|||||
|
2021
Q3 | $18.2M | Buy |
|
|||||
|
2021
Q2 | $21.6M | Buy |
|
|||||
|
2021
Q1 | $23.1M | Sell |
|
|||||
|
2020
Q4 | $31.3M | Sell |
|
|||||
|
2020
Q3 | $27.7M | Sell |
|
|||||
|
2020
Q2 | $35.5M | Sell |
|
|||||
|
2020
Q1 | $29.4M | Sell |
|
|||||
|
2019
Q4 | $42.4M | Sell |
|
|||||
|
2019
Q3 | $46M | Sell |
|
|||||
|
2019
Q2 | $51.4M | Sell |
|
|||||
|
2019
Q1 | $71.3M | Sell |
|
|||||
|
2018
Q4 | $49.1M | Sell |
|
|||||
|
2018
Q3 | $50M | Sell |
|
|||||
|
2018
Q2 | $45.5M | Sell |
|
|||||
|
2018
Q1 | $54.8M | Sell |
|
|||||
|
2017
Q4 | $64.8M | Sell |
|
|||||
|
2017
Q3 | $70.9M | Sell |
|
|||||
|
2017
Q2 | $73.6M | Sell |
|
|||||
|
2017
Q1 | $60.9M | Sell |
|
|||||
|
2016
Q4 | $75.2M | Sell |
|
|||||
|
2016
Q3 | $60.7M | Sell |
|
|||||
|
2016
Q2 | $39.1M | Sell |
|
|||||
|
2016
Q1 | $68.7M | Buy |
|
|||||
|
2015
Q4 | $105M | Sell |
|
|||||
|
2015
Q3 | $71.9M | Sell |
|
|||||
|
2015
Q2 | $105M | Sell |
|
|||||
|
2015
Q1 | $120M | Sell |
|
|||||
|
2014
Q4 | $118M | Buy |
|
|||||
|
2014
Q3 | $71.7M | Sell |
|
|||||
|
2014
Q2 | $66M | Sell |
|
|||||
|
2014
Q1 | $83.9M | Sell |
|
|||||
|
2013
Q4 | $80.3M | Sell |
|
|||||
|
2013
Q3 | $77.5M | Sell |
|
|||||
|
2013
Q2 | $56.9M | Buy |
|